This is just one of such reviews…
Also, initially low price may attract customers, but the accuracy of report matters a lot, since it is based on your reports, your medicine dosage is dependent. E.g. Just by showing a person diabetic is not sufficient, the accurate level decides the dose whether it is 1mg,3mg etc.
To add on : Thyrocare has been charging less since long time vs these guys, still these guys have grown at a healthy rate, again thyrocare is not accepted by doctors.
It is not always a machine based reports, good talent/doctors is needed to verify the reports in case of beyond range values.
The online players follow a cashburn model but this is not sustainable imo. To give an example, prices by Uber/ola is now similar to any normal cab vs if you compare 3 years ago. Low economics is accepted but no economics is never sustainable.
To generate decent margins and healthy sustainable return ratios, you need to charge reasonably and have scale. Suburban despite charging higher than Dr Lal on most tests makes an EBITDA of 16% vs 28% for Dr Lal.